检索结果 - Keith Karcher

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    An Open-Label Extension Study of the Safety and Efficacy of Risperidone in Children and Adolescents with Autistic Disorder

    An Open-Label Extension Study of the Safety and Efficacy of Risperidone in Children and Adolescents with Autistic Disorder 由 Justine Kent, David Hough, Jaskaran Singh, Keith Karcher, Gahan Pandina

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Long-acting injectable risperidone <i>v.</i> olanzapine tablets for schizophrenia or schizoaffective disorder

    Long-acting injectable risperidone <i>v.</i> olanzapine tablets for schizophrenia or schizoaffective disorder 由 Nicholas A Keks, M. Ingham, Akbar Ali Khan, Keith Karcher

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy

    A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuro... 由 Aaron I. Vinik, Douglas Y. Shapiro, Christine Rauschkolb, Bernd Lange, Keith Karcher, Deborah Pennett, Mila Etropolski

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis

    Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis 由 Carlo Antozzi, Jeffrey T. Guptill, Vera Bril, Josep Gámez, Sven G. Meuth, Richard J. Nowak, Dianna Quan, Teresa Sevilla, Marie‐Hélène Jouvin, Jim Jin, Keith Karcher, Sindhu Ramchandren, Hong Sun, Leona Ling, Yaowei Zhu, Santiago Arroyo

    出版 2023
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease

    Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease 由 Reisa A. Sperling, David Henley, Paul Aisen, Rema Raman, Michael Donohue, Karin Ernström, Michael S. Rafii, Johannes Streffer, Yingqi Shi, Keith Karcher, Nandini Raghavan, Yevgen Tymofyeyev, Jennifer Bogert, H. Robert Brashear, Gerald Novak, John Thipphawong, Ziad S. Saad, Hartmuth C. Kolb, Hany Rofael, Panna Sanga, Gary Romano

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: